Medscape: Skin adverse events rare after immunotherapy to treat skin cancers
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found certain skin adverse events were rare following immunotherapy treatments for certain skin cancers.
"Programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors are commonly used drugs for the treatment of various cancers," said Pushkar Aggarwal, MD, corresponding author and medical resident/fellow in UC's College of Medicine. "Having knowledge regarding possible associated skin reactions is vital for clinicians to guide management of the skin reaction and whether an adjustment is needed for the PD-1/PD-L1 inhibitors."
The researchers reviewed adverse event reports for patients treated with PD-1 and PD-L1 treatments between January 2004 and May 2023 to identify whether significant signals exist between PD-1/PD-L1 inhibitors and skin tumors keratoacanthoma and cutaneous squamous cell carcinoma (cSCC).
"For both keratoacanthoma and cSCC, significant signals were found with PD-1/PD-L1 inhibitors," Aggarwal said. But, out of 158,000 cases in the review, the data showed only 43 patients developing keratocanthoma and 83 developing cSCC, which highlights the conditions are "relatively rare adverse events."
Aggarwal said case reports, case-control trials and randomized clinical trials are needed to confirm the results of this study.
Featured photo at top of metastatic melanoma cells. Photo/National Cancer Institute.
Latest UC News
- Local 12: Diabetes study focuses on how long blood sugar control can be maintainedThe University of Cincinnati's Robert Cohen spoke with Local 12 about the GRADE study that shows how a new medication needs to be developed to help treat people with type two diabetes.
- UC alum makes her mark in research, serviceIn 1960, as a young and eager statistician, Joan Reisch graduated from UC’s College of Arts and Sciences, and pursued a career in Texas at the Southwestern Medical Center where she’s held numerous roles as both faculty and staff. This year, Reisch was recognized for her career accomplishments and contributions with the Philanthropist of the Year Award by UC’s Alumni Association. This award is given to an alumnus who has been highly engaged in philanthropic activities with A&S, or has made a significant impact on the college.
- Teeing off a new tradition with UC’s Ed Latessa Memorial Golf OutingOn April 23, 2024, members of the University of Cincinnati’s School of Criminal Justice, part of the College of Education, Criminal Justice, Human Services, and Information Technology (CECH), gathered with family and friends at Glenview Golf Course in Glendale, Ohio, for a round of golf. This wasn’t just any day on the greens, though – this was the inaugural Ed Latessa Memorial Golf Tournament.
- Spectrum News: How to reduce risks of security camera privacy invasionsIndividuals can take steps to protect themselves from privacy invasions, such as ones that led to a more than $5 million settlement with Ring, an Amazon-owned security company, Spectrum News reported.
- Local media cover $13.5 million gift benefiting ALS research and patient careA historic $13.5 million gift from the estate of Hugh H. Hoffman will revolutionize amyotrophic lateral sclerosis (ALS) at the ALS Multidisciplinary Clinic at the University of Cincinnati Gardner Neuroscience Institute.
- New York Magazine: Does eating chocolate actually trigger migraines?The University of Cincinnati's Vincent Martin was featured in a New York Magazine/The Cut article discussing the lack of solid evidence that chocolate is a migraine trigger.